Author

U. Matt

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

S. Herold· 2 shared C. Malainou· 1 shared D. Kresna· 1 shared I. Alexopoulos· 1 shared I. Kuznetsova· 1 shared I. Vazquez-Armendariz· 1 shared J. Better· 1 shared J. I. Findeisen· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

S. Herold

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Nanoliter-scale selection of optimized bioengineered peptide antibiotics that rescue mice with bacterial lung infection

N. Boehringer, Z. G. Wuisan, M. Marner, D. Kresna, U. Mettal, S. Schmitt, S. Reiter, Y. Liu, K. Brinkrolf, O. Rupp, O. Schwengers, J. I. Findeisen, S. Herold, U. Matt, T. F. Schaeberle

This study uses a mutasynthetic library to identify optimized darobactin derivatives that effectively treat bacterial lung infections in mice.

bioRxiv · May 30, 2024 · PreprintMicrobiology

Cell-type-specific efferocytosis determines functional plasticity of alveolar macrophages

J. Better, M. Wetstein, M. Estiri, C. Malainou, M. R. Ferrero, M. Langelage, I. Kuznetsova, I. Vazquez-Armendariz, L. Kimmig, S. Mansouri, R. Savai, J. Wilhelm, I. Alexopoulos, N. Sommer, S. Herold, U. Matt

Neutrophil efferocytosis reprograms mitochondrial metabolism to switch alveolar macrophages to a pro-resolution phenotype at the cost of bacterial control.

bioRxiv · Mar 7, 2023Immunology